当前位置:首页 - 行情中心 - 易明医药(002826) - 财务分析 - 现金流量表

易明医药

(002826)

  

流通市值:33.67亿  总市值:35.08亿
流通股本:1.83亿   总股本:1.91亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金213,713,764.53740,991,846.73556,124,028.43355,669,205.78
  收到的税费返还-1,745.95--
  收到其他与经营活动有关的现金1,155,820.9840,786,496.0443,876,680.7118,592,457.48
  经营活动现金流入小计214,869,585.51781,780,088.72600,000,709.14374,261,663.26
  购买商品、接受劳务支付的现金24,632,881.78119,463,271.4579,027,480.8161,866,443.67
  支付给职工以及为职工支付的现金28,054,288.3183,370,767.3854,125,263.7538,379,984.7
  支付的各项税费24,602,245.5198,064,359.8769,766,770.6146,395,502.18
  支付其他与经营活动有关的现金58,210,388.91357,161,524.23247,483,199.14165,161,318.53
  经营活动现金流出小计135,499,804.51658,059,922.93450,402,714.31311,803,249.08
  经营活动产生的现金流量净额79,369,781123,720,165.79149,597,994.8362,458,414.18
二、投资活动产生的现金流量:
  收回投资收到的现金200,000,000714,000,000434,000,000253,000,000
  取得投资收益收到的现金215,833.343,503,648.941,610,335.981,199,124.71
  处置固定资产、无形资产和其他长期资产收回的现金净额186,000150,218.06169,380168,300
  收到的其他与投资活动有关的现金-3,005,174.13--
  投资活动现金流入小计200,401,833.34720,659,041.13435,779,715.98254,367,424.71
  购建固定资产、无形资产和其他长期资产支付的现金818,138.918,495,636.165,509,804.622,488,305.72
  投资支付的现金400,000,000714,000,000714,000,000503,000,000
  投资活动现金流出小计400,818,138.91722,495,636.16719,509,804.62505,488,305.72
  投资活动产生的现金流量净额-200,416,305.57-1,836,595.03-283,730,088.64-251,120,881.01
三、筹资活动产生的现金流量:
  取得借款收到的现金-22,108,171.3922,108,171.3922,108,171.39
  收到其他与筹资活动有关的现金28,644,00024,510,00024,510,00024,510,000
  筹资活动现金流入小计28,644,00046,618,171.3946,618,171.3946,618,171.39
  偿还债务支付的现金11,249,841.6933,657,536.6618,138,329.7-
  分配股利、利润或偿付利息支付的现金36,811.9823,843,512.1623,675,400.5219,259,991.77
  筹资活动现金流出小计11,286,653.6757,501,048.8241,813,730.2219,259,991.77
  筹资活动产生的现金流量净额17,357,346.33-10,882,877.434,804,441.1727,358,179.62
四、汇率变动对现金及现金等价物的影响-418,483.11-734,015.58-387,406.55-145,109.96
五、现金及现金等价物净增加额-104,107,661.35110,266,677.75-129,715,059.19-161,449,397.17
  加:期初现金及现金等价物余额537,664,815.13427,398,137.38427,398,137.38427,398,137.38
  期末现金及现金等价物余额433,557,153.78537,664,815.13297,683,078.19265,948,740.21
补充资料:
  净利润-93,124,133.45-37,739,129.64
  资产减值准备-1,531,500.61-283,632.71
  固定资产和投资性房地产折旧-17,413,624.13-8,773,881.43
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-17,413,624.13-8,773,881.43
  无形资产摊销-1,722,713.28-1,344,897.85
  处置固定资产、无形资产和其他长期资产的损失-231,318.41-231,283.9
  固定资产报废损失-29,891.21-2,041.87
  财务费用-120,423.33-531,319.66
  投资损失--3,496,674.69--1,193,874.46
  递延所得税--1,834,834.4-299,348.17
  其中:递延所得税资产减少--1,834,834.4-299,348.17
  存货的减少--18,735,945.11--7,878,719.89
  经营性应收项目的减少-26,549,692.58-131,322,954.62
  经营性应付项目的增加-8,842,106.33--109,102,144.77
  其他--1,777,783.34-104,663.45
  现金的期末余额-537,664,815.13-265,948,740.21
  减:现金的期初余额-427,398,137.38-427,398,137.38
  现金及现金等价物的净增加额-110,266,677.75--161,449,397.17
公告日期2026-04-282026-04-282025-10-292025-08-15
审计意见(境内)标准无保留意见
TOP↑